Therefore, to test the possibility, we quantified CpG residue methylation and gene expression at SLC6A4 in cell lines derived from 192 subjects who participated in the latest wave of the Iowa Adoption Studies (IAS). We then analyzed results of these biological assays with respect to the clinical data from their cognate donors to conditions with meta-analytic evidence of serotonergic dysfunction, MD and AD.
